Frontlight ResearchEarly access
Pulmonary arterial hypertension trials in Croatia
1 trial · From ClinicalTrials.gov, checked 17 November 2026. Ask the study team whether a trial fits you.
- Phase 3Enrolling by invitationA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
- Where
- Zagreb
- Age
- 18 years and over
- People
- 1,000 worldwide
- Run by
- United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00